News

Rx EDGE Named DTC Ad Award Finalist in the Most Innovative Category

placeholder

February 18, 2020

Chicago, Illinois

DTC perspectives, and host of DTC National — the largest annual conference focused on direct-to-consumer pharmaceutical marketing — recently announced Rx EDGE® Media Network and Emergent BioSolutions as Ad Award Finalists for the Narcan Media Display program in the Most Innovative category.

Emergent BioSolutions joined with Rx EDGE to develop a program to help raise awareness about the risks of opioids and the life-saving potential of NARCAN® Nasal Spray. Thom Duddy, Vice President, Communications for Emergent BioSolutions emphasized that the risk of opioid overdose is not limited to those who have an opioid use disorder, but can include accidental opioid overdose from those taking opioids as directed who may have other risk factors as well. “The pharmacy is an ideal location for distributing these patient education booklets not only to those who take opioids, but also to family, friends, caregivers and potential first-responders,” said Nate Lucht, Chief Executive Officer, Rx EDGE Media Network.

Select retail pharmacies featured Media Displays in the analgesics aisle offering booklets containing clearly presented educational information. These booklets inform readers about opioid risks, opioid overdoses, and directions for obtaining and administering the life-saving NARCAN® (naloxone HCl) Nasal Spray, the FDA- approved nasal spray administered when an opioid overdose has either occurred or is suspected to have occurred.

The DTC National Advertising Awards are part of the 20th Annual DTC National Conference, held April 22-24 in Boston. The awards program showcases the best marketing and advertising across nearly 20 distinct categories. Gold, Silver, and Bronze winners will be announced during the Advertising Awards Dinner held on Thursday April 23.

View the 2020 Ad Award Finalists

For more information about DTC National Conference visit:
http://dtcperspectives.com/dtcn/about-dtcn/

About Rx EDGE® Media Network

More than 70 pharma companies spanning 185 therapeutic categories have leveraged the power of Rx EDGE® Media Network because they recognize the importance of the pharmacy channel as an education and communication channel. Rx EDGE® delivers patients to brands through unique online and in-aisle resources with the potential to reach millions of consumers looking for guidance, health services, and prescriptions across the pharmacy network.

About Emergent BioSolutions

Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats. We aspire to be a Fortune 500 company recognized for protecting and enhancing life, driving innovation, and living our values. Additional information about the company may be found at www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Contact:

Rx EDGE® Media Network
Kathleen Bonetti, EVP Marketing

(847) 879-6036
kathleen.bonetti@rx-edge.com
www.rxedge.com

Emergent BioSolutions
Thom Duddy, Vice President - Communications

(484) 532 5470
duddyt@ebsi.com
www.emergentbiosolutions.com

Other News You Might Like


December 16, 2019

Unlimited™ Named One of the Most Innovative Products of 2019

A publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named Rx EDGE’s Unlimited™ one of the most innovative…

Read Morearrow

September 19, 2019

Rx EDGE and Emergent BioSolutions Launch Narcan® (naloxone HCI) Nasal Spray Information Initiative

To help combat the major opioid public health epidemic and crisis, Rx EDGE® Media Network has partnered with Emergent BioSolutions to provide urgently needed and vital educational…

Read Morearrow